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Abstract Fasciolosis is a hepatic parasitic infection that
affects many mammal species and creates a great economic
and veterinary problem. Molecular mechanisms of parasite–
hepatocyte interactions have not been precisely character-
ized yet. Therefore, the aim of the study was to investigate
alterations in the metabolic activity of rat liver cells
exposed to Fasciola hepatica somatic proteins. Hepatocytes
were incubated with 0–1 mg/ml of fluke's somatic proteins
for various periods of time. Afterward, changes in hep-
atocytes metabolic activity were determined with MTT and
enzyme leakage tests. Hepatocytes' capacity to synthesize
albumin was also investigated. It was observed that protein
concentration, as well as longevity of their action, influ-
enced metabolic activity of rat liver cells. Diminution of
hepatocytes survival rate, an increase in enzyme leakage
and altered synthetic capacity after treatment with parasite's
proteins were reported. It is concluded that somatic proteins
of F. hepatica may play an important role in liver cell
damaging.
Introduction
Fasciolosis, a disease caused by Fasciola hepatica, affects
many mammal species, mainly ruminants, and occasionally
man. It is considered as a great economic and veterinary
problem in livestock production, in particular, in sheep and
cattle. Economic losses derive from decreased weight gain,
fertility, milk yield, wool production and sudden deaths of
heavily infected animals. The majority of damage caused in
the liver arises from suckers action and spiny tegument
abrasions as parasite migrates through the liver parenchy-
ma. Mechanical damage is accompanied by cellular
inflammatory reaction generated by the host, which leads
to immunopathogical condition. Haemorrhage, necrosis,
fibrosis and cirrhosis are common findings during the
disease. It has been proposed that somatic and/or secreted
molecules of the parasite may contribute to hepatic
dysfunction. However, molecular mechanisms of parasite–
hepatocyte interactions have not been precisely character-
ized yet. It is known, that some aspects of liver functions
such as carbohydrate, protein, lipid, steroid and mitochon-
drial bioenergetic metabolism have been altered. It has been
reported that during fasciolosis, oxidative damage to
hepatocytes occurs what was confirmed by indicator
enzymes leakage and the presence of lipid peroxidation
products in livers and sera of infected animals. In previous
work, authors presented that excretory–secretory products
of F. hepatica play a significant role in rat hepatocytes
damaging (Gajewska et al. 2006). The role of somatic
proteins in that process has not been characterized yet.
Thus, the aim of this study was to examine the effect of F.
hepatica somatic proteins on enzymatic systems, albumin
metabolism and survival rate of hepatocytes.
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F. hepatica somatic proteins Adult specimens of F. hepatica
were obtained from slaughterhouse in Białystok. Flukes
were homogenized in TBS buffer (0.15 M NaCl, 0.02 M
TRIS, 0.1 mM PMSF, 0.5 mM EDTA) at 4°C. For 1 mg of
parasite, 3 μl of buffer were used. Following centrifugation
(15,000×g, 4°C, 30 min), supernatant was collected and
stored at −20°C. Afterward, pellet was resuspended in SDS
buffer (TBS buffer with 1% SDS) in proportion of 3 μlo f
buffer for 1 mg of fluke. Probes were then placed for 5 min
at 100°C, and subsequently for 20 min at 4°C. After
centrifugation (15,000×g, 4°C, 30 min), supernatant was
collected and stored at −20°C. TBS fraction contained
soluble proteins, whereas SDS fraction contained
membrane-bound proteins. Protein concentration was esti-
mated due to Lowry et al. (1951) method.
Experimental animals Twenty male 2-month-old Wistar
rats were maintained in plastic cages, fed and watered ad
libidum in natural photoperiod condition. Livers were
prepared from anaesthetized animals and then hepatocytes
were isolated according to INVITTOX No. 20 (1999)
protocol recommended by ECVAM. Trypan blue exclusion
test was used to determine the number of viable hepatocytes
present in a cell suspension, and suspensions with viability
higher than 75% were taken to further analysis.
Survival rate of rat hepatocytes exposed on F. hepatica
somatic proteins Isolated hepatocytes were cultured in 96-
well plates in concentration of 50,000 cells per well in
Williams' E medium (Sigma) supplemented with 5% foetal
bovine serum (Sigma) and 1× antibiotic antimycotic
solution (Sigma). Cells were maintained in a 5% CO2
atmosphere at 37° and 100% humidity. Plates were placed
in an incubator for 12 h to allow cell adhesion; afterward,
appropriate concentrations of somatic proteins were added
(0.00, 0.02, 0.05, 0.1, 0.2, 0.4, 1 mg/ml). Hepatocytes were
cultured for 2, 6, 12, 24, 48 and 72 h. Whenever time of
incubation ended, MTT reduction test was assayed. Hep-
atocytes survival rate in control cells (non-treated with
proteins) was assented as 100%, and against that value,
percentage of survival rate of treated with proteins cells was
calculated.
Enzymatic systems and albumin production in hepatocytes
after exposure to F. hepatica somatic proteins Hepatocytes
were cultured in 6-well plates in concentration of 2×10
6 per
well in the same conditions as those presented above.
Concentration of proteins from both somatic fractions were
Table 1 TBS fraction effect on hepatocytes survival rate
TBS fraction concentration
[mg/ml]
Percentage of survival rate
2h 6h 1 2h 2 4h 4 8h 7 2h
0.02 86.70±11.2 88.10±12.0 84.10±6.8
a 83.90±9.3
a 83.90±9.3
a 77.00±15.6
a
0.05 86.60±9.7 86.00±10.1 84.90±10.0
a 82.40±10.0
a 79.80±7.5
a 75.50±14.2
a
0.10 90.50±10.8 83.30±8.5
a 82.80±5.4
a 80.50±8.4
a 73.60±10.3
a 67.10±13.3
a
0.20 89.00±12.1 81.80±4.9
a 79.00±10.2
a 78.5±5.3
a 71.20±9.4
a 73.30±10.2
a
0.40 88.00±7.2
a 81.50±7.8
a 80.80±8.6
a 75.50±10.5
a 73.60±10.8
a 71.60±8.5
a
1.00 89.50±9.1
a 75.80±9.2
a 76.20±9.5
a 75.80±14.3
a 72.30±13.1
a 74.40±15.2
a
aSignificantly different from control group (P<0.05)
Table 2 SDS fraction effect on hepatocytes survival rate
SDS fraction concentration
[mg/ml]
Percentage of survival rate
2 h 6 h 12 h 24 h 48 h 72 h
0.02 86.10±10.3 90.20±9.5 86.60±7.4 80.20±6.5
a 78.30±10.2
a 77.40±11.2
a
0.05 85.80±11.3 91.50±6.4 82.00±7.8
a 75.60±7.7
a 79.60±8.6
a 76.20±10.5
a
0.10 85.40±12.1 82.70±10.4
a 79.00±10.4
a 76.70±9.5
a 76.70±11.2
a 73.30±9.6
a
0.20 80.80±8.5
a 80.30±13.2
a 78.00±13.2
a 76.30±8.8
a 72.70±10.4
a 70.10±14.7
a
0.40 70.50±6.3
a 67.90±10.30
a 55.40±13.2
a 56.70±15.3
a 60.70±15.3
a 57.20±12.7
a
1.00 67.60±10.2
a 65.10±6.9
a 61.30±10.4
a 53.80±14.3
a 54.50±12.9
a 50.30±7.8
a
aSignificantly different from control group (P<0.05)
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were 2,6, 12, 24, 48 and 72 h. Whenever time of incubation
ended, samples of post-incubation medium were collected
and activities of aspartate transaminase (AST), alanine
transaminase (ALT), lactate dehydrogenase (LDH-L),
gamma-glutamyl-transpeptidase (γ-GT), alkalic phospha-
tase (ALP) and albumin level were measured (Pointe
Scientific tests). Additionally, untreated with proteins,
culture cells were treated with ultrasounds to measure total
enzyme activity and albumin level in hepatocytes. Results
were presented as a percentage of enzyme activity, or
albumin level reported in a post-incubation medium in
relation to total enzyme activity, or albumin level in cell
suspension.
Statistical analysis By means of unpaired Student's t test,
statistical analysis was done. Results were presented as a
mean with standard deviation (p< 0 . 0 5i nr e l a t i o nt o
control).
Results
Survival rate of hepatocytes after exposure to F. hepatica
somatic proteins decreased with the time of incubation and
increasing fluke protein concentration (Tables 1 and 2). The
observed declines were higher in cells incubated with SDS
fraction (e.g. after 72 h incubation with TBS fraction in
concentration of 1.0 mg/ml 74.4% of hepatocytes were
viable; in the same configuration with SDS fraction, only
50.3% hepatocytes were viable).
AST, ALT, LDH-L leakage from cells to medium
escalated as the time of incubation progressed and protein
concentration increased. However, the time of exposition
was a critical factor affecting the value of influx (Tables 3,
4, 5, 6, 7 and 8). The influence of the type of a fraction
used was also reported, higher enzymatic activities in post-
incubation media were observed when hepatocytes were
treated with proteins from SDS fraction.
Moreover, ALP and G-GT were released from cells
during the experiment (Tables 9, 10, 11 and 12). Increasing
protein concentration had no impact on enzymatic leakage.
Longevity of exposure to parasite proteins had a decisive
role in that process.
As compared to control cells, in hepatocytes exposed to
F. hepatica proteins, a significant decline in albumin
synthesis occurred (Tables 13 and 14). When cells were
incubated with SDS fraction, percentage of albumin
released to medium was lower than in the case of cells
treated with TBS fraction (for e.g. after 2 h exposure to
1 mg/ml SDS fraction, percentage of albumin released to
Table 3 TBS fraction effect on percentage of released aspartate transaminase (AST) from hepatocytes
TBS fraction concentration
[mg/ml]
Percentage of released AST
2 h 6 h 12 h 24 h 48 h 72 h
0.05 8.69±3.2 11.60±4.7 16.20±2.3
a 16.63±4.3
a 16.96±5.3
a 17.72±4.5
a
0.10 8.78±4.3 15.80±4.3 17.30±4.2
a 17.55±6.3
a 17.98±9.2
a 20.76±5.3
a
0.20 10.55±5.2 14.90±7.2 17.81±4.9
a 17.64±5.5
a 23.24±7.4
a 28.46±6.1
a
0.40 17.05±6.8
a 19.80±3.4
a 18.40±5.1
a 18.31±4.9
a 23.21±6.8
a 29.97±4.1
a
1.00 13.42±6.2 18.00±2.5
a 17.72±3.7
a 18.40±7.3
a 27.95±10.1
a 28.87±8.4
a
aSignificantly different from control group (P<0.05)
Table 4 SDS fraction effect on percentage of released aspartate transaminase (AST) from hepatocytes
SDS fraction concentration
[mg/ml]
Percentage of released AST
2 h 6 h 12 h 24 h 48 h 72 h
0.05 6.41±4.9 12.11±4.9 15.11±3.2
a 17.81±3.8
a 16.33±4.6
a 23.75±9.7
a
0.10 7.68±2.6 16.46±4.2
a 15.36±6.6
a 18.05±3.7
a 17.13±5.2
a 21.27±5.4
a
0.20 6.58±4.3 15.87±6.1
a 18.40±3.9
a 20.00±5.3
a 21.01±4.9
a 27.68±6.4
a
0.40 11.14±8.3 18.15±3.2
a 19.50±7.4
a 24.30±8.3
a 25.82±6.8
a 30.38±8.6
a
1.00 12.15±7.2 18.31±2.5
a 21.52±6.8
a 26.16±10.4
a 27.70±11.1
a 34.60±12.4
a
aSignificantly different from control group (P<0.05)
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albumin reported in post-incubation medium after 2 h
exposure to 1 mg/ml TBS fraction amounted to 39.6%).
Discussion
In somatic extracts from F. hepatica, many parasitic
proteins are detected, among which molecules of pivotal
importance for fluke are present (SDS-PAGE analysis, data
not shown). To date, numerous parasite somatic proteins
were identified and characterized. Some of them, such as
fatty acid binding proteins, glutathione S-transferases,
cathepsin L, haemoglobin, Kunitz-type serine inhibitors,
phosphoglycerate kinase, were tested as vaccine antigens
(Spithill et al. 1999; Hillyer 2005; Jaros et al. 2010).
However, molecular interactions between hepatocytes and
F. hepatica proteins are not characterized very well, and the
role of somatic proteins in liver cell damaging have not
been revealed. Precise causes of pathology that is observed
during the liver fluke infection are still unknown.
Results received in the present experiments suggest that
relation between the decline of hepatocytes survival rate
and parasite somatic protein concentration, as well as
longevity of their action, exist. The higher protein concen-
tration and longer incubation time is, the higher reported
decline of survival rate appears to be. This dependence is
more pronounced in cells treated with SDS fraction than in
the cells exposed to proteins from TBS fraction. It is
believed that SDS has no toxic effect on rat liver cells since
its concentration in final dilution is lower than 0.01%.
Moreover, significant differences in survival rate values
between hepatocytes treated with increasing SDS fraction
concentrations were not observed. The decrease in hepato-
cytes viability may be explained by disturbances in cellular
membranes' function and structure. It has been observed
that in livers of infected rats, phospholipid and total lipid
compounds dramatically decline as the infection progresses
(Lenton et al. 1995). Since significant increase in their
degradation products or precursors occurs (in particular,
non-esterified fatty acids), phospholipase is suggested to
have an elevated activity. Moreover, concentration of lipid
peroxidation products, such as malondialdehyde, 4-
hydroxyketonal and conjugated dienes in liver preparations
increases, what is accompanied by lowered antioxidant
enzymes activities in serum (Kolodziejczyk et al. 2005,
2006; Kaya et al. 2006). It appears to be the direct evidence
for oxidative damage to hepatic lipids in F. hepatica-
infected animals (Siemieniuk et al. 2008). Alterations in
phospholipids content in hepatic membranes lead to many
functional changes, among which are respiratory aberra-
tions in mitochondria. It has been reported that mitochon-
Table 5 TBS fraction effect on percentage of released alanine transaminase (ALT) from hepatocytes
TBS fraction concentration
[mg/ml]
Percentage of released ALT
2 h 6 h 12 h 24 h 48 h 72 h
0.05 4.63±1.2 6.68±1.1 7.10±2.5 11.00±2.1
a 13.90±2.1
a 13.30±6.9
a
0.10 7.98±1.5 8.48±1.8 11.10±1.4 11.50±1.8
a 14.02±2.7
a 15.40±3.5
a
0.20 9.64±1.9 10.21±2.3 11.25±1.8
a 13.40±1.6
a 17.97±2.6
a 21.50±2.4
a
0.40 10.34±0.9 12.40±0.9
a 12.26±1.2
a 13.25±1.6
a 20.36±2.7
a 22.80±4.2
a
1.00 12.68±2.0
a 14.00±1.5
a 14.76±2.9
a 14.74±3.0
a 21.10±3.7
a 26.20±6.9
a
aSignificantly different from control group (P<0.05)
Table 6 SDS fraction effect on percentage of released alanine transaminase (ALT) from hepatocytes
SDS fraction concentration
[mg/ml]
Percentage of released ALT
2 h 6 h 12 h 24 h 48 h 72 h
0.05 9.68±3.4 10.40±3.6 12.05±3.1 15.08±2.9
a 16.40±5.5
a 15.70±6.3
a
0.10 9.82±5.2 10.70±4.2 12.30±2.7 17.40±6.3
a 16.40±2.7
a 20.80±3.5
a
0.20 10.13±2.9 12.00±5.3 15.30±5.3
a 16.00±3.2
a 22.30±6.3
a 23.60±4.7
a
0.40 15.12±6.3
a 14.70±5.2
a 20.40±6.4
a 28.90±7.4
a 32.00±6.7
a 37.20±6.9
a
1.00 19.84±7.1
a 18.60±4.8
a 20.50±4.5
a 30.60±5.4
a 37.50±8.1
a 40.04±10.2
a
aSignificantly different from control group (P<0.05)
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to ATP synthesis, what is essential for all cellular functions
(Rule et al. 1989). Consequently, ATP concentration in liver
extracts from infected rats decreases as compared with
uninfected animals. In addition, changes in mitochondrial
membrane permeability are also noticed since mitochondria
became permeable to NADH, to which they are normally
impermeable (Lenton et al. 1994). Moreover, it was noted
that F1F0-ATPase losses its oligomycin sensitivity. Intact
rat's hepatocytes demonstrate also abnormal permeability
(Hanisch et al. 1992). It was also found that mitochondria
isolated from livers of infected animals contain elevated
concentration of non-esterified fatty acids, what may be
responsible for their uncoupled state (Lenton et al. 1995).
Another consequence of diminished phospholipid content is
increased permeability of hepatocytes. It was suggested that
lysosomes as well as cellular membranes are disrupted,
what in consequence can lead to leakage of lysosomal
enzymes into the cytosol and next into cellular space
(Siemieniuk et al. 2008). Enzymes such as cathepsin B may
play carcinogenic role when released into extracellular
space (Skrzydlewska et al. 2005). Nevertheless, F. hepatica
infection is not accompanied by carcinogenic action.
In the present study, alterations in hepatic membranes
integrality were confirmed by the leakage of indicator
enzymes from liver cells. Changes in levels of hepatic
enzymessuchasAST,ALT,LDH-L,areindicatorscommonly
used to monitor fasciolosis progress (Kolodziejczyk et al.
2005;K a y ae ta l .2006). In vivo experiments conducted by
Jemli et al. (1993)a n dF e r r ee ta l .( 1996)d e m o n s t r a t e dt h a t
aminotransferases and dehydrogenase activities in sera of
animals infected with F. hepatica are elevated. Their
activities increase significantly during early infection, when
parasite migrates through liver parenchyma, and reach a
peak value at the end of the parenchymal stage of the
disease. During biliary stage, these enzyme activities
decrease, but remain higher than in uninfected controls.
Results received show that maximal enzyme leakage values
observed in this study are related to the highest declines of
hepatocytes survival rates. It leads to the conclusion that as
the time of incubation with parasite extracts is lengthening,
more severe damage to hepatic membranes occurs, which
may result in cell death. Influence of parasite extract used on
enzyme leakage is also observed. Proteins from SDS fraction
display more toxic properties on rat hepatocytes. Addition-
ally, ALP and γ-GT activities in post-incubation medium
were also measured. Those enzymes are localized in hepatic
membranes. Moreover, γ-GT is an indicator of damage to
bile ducts, and its activity peak follows the peaks of the AST,
ALT, LDH-L in vivo. Increases of ALP and γ-GT activities
in post-incubation medium confirm the severe membrane
damage.
Table 7 TBS fraction effect on percentage of released lactate dehydrogenase (LDH-L) from hepatocytes
TBS fraction concentration
[mg/ml]
Percentage of released LDH-L
2h 6h 1 2h 2 4h 4 8h 7 2h
0.05 6.89±1.4 10.19±3.5 11.94±2.9
a 13.68±4.2
a 14.12±3.7
a 21.69±2.2
a
0.10 9.46±2.4 9.32±3.2 12.37±1.7
a 18.20±1.9
a 17.18±3.4
a 23.44±4.1
a
0.20 6.55±2.5 9.90±2.4 12.40±1.8
a 19.36±1.7
a 24.75±4.8
a 27.95±3.9
a
0.40 9.90±1.8 11.21±4.5 15.53±2.2
a 19.51±49
a 27.75±3.2
a 29.88±3.3
a
1.00 9.50±1.2 9.75±1.5 14.12±1.6
a 19.65±3.3
a 28.90±6.7
a 29.65±5.1
a
aSignificantly different from control group (P<0.05)
Table 8 SDS fraction effect on percentage of released lactate dehydrogenase (LDH-L) from hepatocytes
SDS fraction concentration
[mg/ml]
Percentage of released LDH-L
2h 6h 1 2h 2 4h 4 8h 7 2h
0.05 3.09±1.5 7.02±1.4 9.93±4.2 10.07±3.8 20.41±7.5
a 26.82±6.8
a
0.10 4.25±1.6 6.87±2.3 10.66±1.7 11.09±3.7 20.27±3.6
a 24.05±6.6
a
0.20 4.50±1.9 7.16±2.4 8.04±2.5 10.37±2.8 21.14±8.4
a 25.22±8.4
a
0.40 3.23±0.9 7.31±1.4 12.55±5.3 17.09±5.4
a 24.04±4.7
a 33.58±11.6
a
1.00 2.65±1.7 7.60±1.7 12.40±6.4 17.28±5.6
a 28.01±7.9
a 30.04±12.4
a
aSignificantly different from control group (P<0.05)
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Liver is the only site of albumin synthesis, and liver
damage compromises functions of that organ, what is
reflected in a decline of plasma albumin concentrations.
Albumin concentration in post-incubation medium was
evaluated in the experiment. When cells were treated with
parasite somatic proteins, gradual increase and then decline
in albumin concentration was reported. It confirms that
hepatocytes are metabolically active, but it must be stressed
that at the beginning of the experiment, albumin released
might be synthesized earlier, or may leak out through
damaged membranes. However, when cells are incubated
longer with proteins, the decline in albumin concentration is
evident, and it implies that alterations in albumin synthesis
occur. The results obtained suggest that proteins from SDS
fraction have more toxic influence on rat liver cells than
proteins from TBS fraction. It is known from literature data
that progressive loss of plasma albumin is common in all
infected host species. That loss can be explained by reduced
rate of synthesis and by expansion of the plasma volume
(Behm and Sangster 1999). Now it is being suggested that
somatic proteins of F. hepatica may interfere with albumin
synthesis and contribute to lower albumin level in plasma
of infected animals.
It is concluded that somatic proteins derived from F.
hepatica may participate in hepatic damage and may
contribute to cell death. TBS and SDS fractions cause
lower survival rate of rat liver cells, indicator enzyme
leakage and alterations in albumin synthesis. The extent of
the damages depends on the protein concentration and
longevity of their action. Since hepatocytes are being
damaged by parasite molecules, it may be expected that F.
hepatica somatic proteins play an important role in liver
cell damaging, and contribute to liver pathogenesis during
fasciolosis. Those proteins may be released from dead
parasites which fail to establish in the bile ducts. It is a
well-studied phenomenon that the majority of the migrating
parasites does not develop to adult stages and become
trapped in the liver parenchyma. In naive sheep and cattle
infected with F. hepatica, metacercariae adult flukes
recovery percentages are 16–53% and 11–21%, respectively
(Spithill et al. 1999). It is expected that abundance of
somatic proteins is released after parasite's death and may
exert their effect on hepatocytes. Liver cells may also be
exposed to proteins which are located at parasite's surface.
Surface proteins may be released during glycocalyx
shedding, as well as replacement of damaged tegument.
Glycocalyx shedding is a way of evading of immunological
attack of the host. In the juvenile stages, continuous
glycocalyx turnover occurs approximately every 3 h
(Hanna 1980). In turn, tegumental destruction is associated
with immune-related damage from the host. Fluke's
attempts are to substitute damaged structure with a
formation of a new one underneath (Bennet et al. 1980).
Table 9 TBS fraction effect on percentage of released alkalic phosphatase (ALP) from hepatocytes
TBS fraction concentration
[mg/ml]
Percentage of released ALP
2h 6h 1 2h 2 4h 4 8h 7 2h
0.05 0.5±0.4 0.4±0.1 1.3±0.2 1.5±0.3 6.2±1.9 10.5±4.6
0.10 1.2±0.8 0.9±0.5 1.2±0.4 1.3±0.1 5.1±0.2 10.7±1.1
0.20 1.3±0.5 0.8±0.5 1.3±0.3 1.5±0.2 6.4±1.9 10.6±2.3
0.40 1.7±0.8 1.0±0.8 1.5±0.2 1.9±0.3 5.9±1.3 10.0±1.5
1.00 0.8±0.4 1.0±0.4 1.6±0.5 1.8±0.5 4.9±1.6 10.7±2.4
aSignificantly different from control group (P<0.05)
Table 10 SDS fraction effect on percentage of released alkalic phosphatase (ALP) from hepatocytes
SDS fraction concentration
[mg/ml]
Percentage of released ALP
2h 6h 1 2h 2 4h 4 8h 7 2h
0.05 1.0±0.5 2.0±0.3 4.1±1.6 4.3±1.7 11.0±2.2
a 13.2±3.1
a
0.10 1.5±0.3 2.1±0.4 5.1±1.2 4.4±1.1 11.3±1,1
a 12.9±1.3
a
0.20 1.7±0.2 2.4±0.7 4.9±1.3 4.8±1.8 12.90±1.2
a 15.1±2.5
a
0.40 2.0±0.5 2.5±1.1 6.0±2.2 6.3±2.1 11.9±1.4
a 12.5±3.2
a
1.00 2.2±1.2 2.4±0.3 6.2±2.3 6.8±1.9 11.6±1.1
a 10.9±3.2
a
aSignificantly different from control group (P<0.05)
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TBS fraction concentration
[mg/ml]
Percentage of released γ-GT
2 h 6 h 12 h 24 h 48 h 72 h
0.05 9.08±2.4 11.67±3.0 11.91±2.6
a 12.62±2.1
a 21.51±2.7
a 22.45±5.6
a
0.10 12.15±2.5 10.73±2.8 8.96±2.4 12.74±1.7
a 20.75±3.6
a 21.89±2.6
a
0.20 9.67±3.2 10.85±2.3 12.85±2.2
a 12.74±1.6
a 22.08±5.2
a 24.15±3.9
a
0.40 8.73±1.9 10.85±3.1 12.50±1.2
a 13.21±1.6
a 19.06±5.4
a 22.83±5.8
a
1.00 9.43±2.1 11.08±2.6 12.15±2.8
a 13.44±3.4
a 21.51±3.1
a 22.64±3.2
a
aSignificantly different from control group (P<0.05)
Table 12 SDS fraction effect on percentage of released gamma-glutamyl-transpeptidase (γ-GT) from hepatocytes
SDS fraction concentration
[mg/ml]
Percentage of released γ-GT
2 h 6 h 12 h 24 h 48 h 72 h
0.05 10.24±2.8 10.38±4.7 11.44±2.7 11.08±2.2 16.79±4.7
a 17.55±7.1
a
0.10 12.97±4.6 10.26±4.8 11.32±2.8 12.26±5.6 17.36±3.6
a 19.06±4.7
a
0.20 10.50±4.3 10.38±6.2 13.33±3.1
a 13.44±1.9
a 19.25±3.7
a 21.70±9.8
a
0.40 10.50±5.2 10.85±6.2 13.09±3.2
a 13.33±5.7
a 20,99±7.4
a 21.93±8.5
a
1.00 10.61±6.1 11.08±3.8 13.21±4.1
a 13.56±5.4
a 19.58±9.1
a 20.99±6.7
a
aSignificantly different from control group (P<0.05)
Table 13 TBS fraction effect on percentage of released albumin from hepatocytes
TBS fraction concentration
[mg/ml]
Percentage of released albumin
2 h 6 h 12 h 24 h 48 h 72 h
0.05 17.50±5.6
a 25.30±2.1
a 31.80±4.0
a 35.10±3.1
a 39.60±4.5
a 35.10±2.2
a
0.10 36.40±3.1
a 39.60±2.9
a 44.20±6.7
a 42.20±4.7
a 44.80±8,1
a 32.50±1.3
a
0.20 35.70±5.4
a 44.20±8.4
a 29.20±10.1
a 35.70±8.8
a 45.50±7.2
a 36.40±1.4
a
0.40 36.40±3.8
a 41.60±4.6
a 33.10±9.6
a 31.20±3.4
a 35.10±3.9
a 32.50±2.3
a
1.00 39.60±2.7
a 48.70±9.5
a 37.70±11.6
a 32.50±7.2
a 29.20±3.1
a 31.80±3.0
a
aSignificantly different from control group (P<0.05)
Table 14 SDS fraction effect on percentage of released albumin from hepatocytes
SDS fraction concentration
[mg/ml]
Percentage of released albumin
2 h 6 h 12 h 24 h 48 h 72 h
0.05 12.20±6.3 22.80±2.7
a 21.70±10.5
a 22.30±11.4
a 38.00±5.8
a 33.70±6.4
a
0.10 10.30±2.4 19.00±5.3
a 21.70±6.7
a 23.90±5.5
a 39.10±7.2
a 29.30±6.6
a
0.20 10.90±3.7 26.10±7.4
a 23.90±10.1
a 22.30±7.6
a 34.80±6.3
a 27.70±7.3
a
0.40 17.40±2.9
a 26.60±4.6
a 30.40±9.6
a 29.30±3.4
a 34.80±11.3
a 31.00±2.6
a
1.00 17.90±2.6
a 27.70±7.3
a 29.90±11.60
a 31.50±7.2
a 31.50±10.4
a 26.60±9.5
a
aSignificantly different from control group (P<0.05)
Parasitol Res (2012) 110:395–402 401Eventually, within fractions that were examined in a present
study, secretory protein presence is also possible as the
molecules are synthesized in cells and are known to have
damaging impact on hepatocytes (Gajewska et al. 2006).
Parasite proteins, especially those present in SDS fraction,
may be a good source for searching new antigen candidates
for vaccination against F. hepatica. The development of
new effective strategies for the control of fasciolosis is
currently urgently needed.
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